Cardiovascular Systems, Inc. to Attend Three Investor Conferences in August

ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to attend three investor conferences in August.

Guggenheim MedTech Disruptors Summit
Tuesday, August 10, 2021

Canaccord Genuity 41st Annual Growth Conference
Wednesday, August 11, 2021
12:30 p.m. ET
Webcast of presentation

6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
Tuesday, August 17, 2021

About Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For additional information, please visit www.csi360.com and connect on Twitter @csi360.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210727005130/en/

Cardiovascular Systems, Inc.
Jack Nielsen
Vice President, Investor Relations
& Corporate Communications
(651) 202-4919
[email protected]

Source: Cardiovascular Systems, Inc.

You May Also Be Interested In

• The Trade Desk hit by Wall St downgrades after disappointing Q2 results, outlook
• RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias
• XRP Price Prediction: XRP Defends $1 Support as AlphaPepe’s $0.02501 Entry Builds the Smaller-Cap Upside Case